Loading clinical trials...

The Effects of A Proprietary Spearmint Extract on Cognitive Performance | Clinical Trials | Clareo Health

COMPLETEDNA

The Effects of A Proprietary Spearmint Extract on Cognitive Performance

A Randomized, Double-Blind, Placebo-Controlled, Parallel Trial to Assess the Effects of A Proprietary Spearmint Extract on Cognitive Performance, Mood, and Sleep in Men and Women

NCT02518165•Kemin Foods LC

View on ClinicalTrials.gov

Summary

This study was designed to evaluate the chronic effects of a proprietary spearmint extract over 90 days of supplementation on aspects of cognitive performance (cognitive function and active reaction time), subjective mood, and sleep quality in healthy men and women.

Eligibility

Age

18 - 50 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Men and pre-menopausal women, 18-50 years of age.
•Body mass index 18.5-29.99 kg/m2, inclusive or body mass index 30.0-34.99 kg/m2 and body fat via bioimpedance \<39% for women aged 18-39y, \<40% for women aged 40-50y, \<25% for men aged 18-39y, \<28% for men aged 40-50y.
•Participant has at least a high school diploma or the equivalent.
•Participant is recreationally active.
•Participant is judged by the Investigator to be in general good health.
•Participant understands the study procedures and signs forms providing informed consent to participate in the study and authorization for release of relevant protected health information to the study Investigators.

Exclusion Criteria

•Participant is unable to understand and/or perform required tests.
•Participant is unwilling to maintain normal dietary (including vitamins and supplements), exercise, sleep and medication patterns throughout the study.
•Participant is a habitual consumer of mint tea defined as \>8oz per day.
•Participant is regularly taking a cognitive enhancing supplement.
•Participant has a history or presence of a clinically important cardiac, renal, hepatic, endocrine, pulmonary, biliary, gastrointestinal, pancreatic, or neurologic disorder.
•Participant has a sleep disorder or occupation where sleep during the overnight hours is irregular.
•Participant is pregnant, planning to be pregnant during the study period, lactating, or is of childbearing potential and is unwilling to commit to the use of a medically approved form of contraception throughout the study period.
•Participant is a current user of tobacco (defined as tobacco use within the previous 6 months).

Locations (1)

Musclepharm Sports Science Institute

Denver, Colorado, United States

Key Dates

Start Date

April 1, 2015

Primary Completion Date

January 1, 2017

Completion Date

April 1, 2017

Last Updated

January 31, 2018

Enrollment

142

ACTUAL participants

Conditions

MoodCognitive PerformanceSleep

Interventions

Proprietary spearmint extract

DIETARY_SUPPLEMENT

Placebo

OTHER

OSA Risk Level in Dental Patients and Correlation With Complications After General Anesthesia

NCT06430957

Obstructive Sleep Apnea Risk ManagementPostoperative Complications+2 more

View study

RECRUITING

Studying Childhood-onset Behavioral, Psychiatric, and Developmental Disorders

NCT01778504

Neuropsychiatric DisorderNeurological Disorder+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 31, 2018Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

The Effects of A Proprietary Spearmint Extract on Cognitive Performance

Inclusion Criteria

Exclusion Criteria

OSA Risk Level in Dental Patients and Correlation With Complications After General Anesthesia

Studying Childhood-onset Behavioral, Psychiatric, and Developmental Disorders

Transcutaneous Auricular Vagus Nerve Stimulation and Spirometry: Sham-Controlled Randomized Trial

Light Exposure, Migraine Outcomes, and Sleep Quality

MyVitalC: Sleep and Everyday Headache Management

Digital-supported Orofacial Myofunctional Therapy in OSA